(Q72753112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

G E Umbach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

V Hug

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

G Spitzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Thames

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

B Drewinko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

263-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00175374

29 October 2019

exact match

0 references

cites work

Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs

1 reference

12 December 2020

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancers

1 reference

12 December 2020

The growth of mouse bone marrow cells in vitro

1 reference

12 December 2020

Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388

1 reference

12 December 2020

Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells

1 reference

12 December 2020

Colony stimulating factor augmentation in human placental conditioned medium

1 reference

12 December 2020

Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells

1 reference

12 December 2020

Phase I trial of homoharringtonine

1 reference

12 December 2020

Patterns of cell survival following treatment with antitumor agents in vitro

1 reference

12 December 2020

The antitumor effects and pharmacologic actions of harringtonine

1 reference

12 December 2020

Harringtonine in acute leukemias. Clinical analysis of 31 cases

1 reference

12 December 2020

Phase I trial of homoharringtonine administered as a 5-day continuous infusion.

1 reference

12 December 2020

Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00175374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6210262%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference